PTPN18 and breast carcinoma: Our extensive analysis of PTPN18 in EMT and metastasis indicated that nuclear PTPN18 but not cytoplasmic PTPN18 antagonized TGFβ signaling-regulated EMT and reduced the metastatic ability of breast cancer cells through regulation of ETS1 phosphorylation in breast cancer (Fig. 7).